Literature DB >> 27306750

The use of oral antibiotics in treating acne vulgaris: a new approach.

Georgia Farrah1, Ernest Tan2.   

Abstract

Although acne is not an infectious disease, oral antibiotics have remained a mainstay of treatment over the last 40 years. The anti-inflammatory properties of oral antibiotics, particularly the tetracyclines, are efficacious in treating inflammatory acne lesions. Common prescribing practices in Dermatology exert significant selection pressure on bacteria, contributing to the development of antibiotic resistance. Antibiotic use for acne not only promotes resistance in Propionibacterium acnes, but also affects other host bacteria with pathogenic potential. This review will summarize the commonly used treatments for acne vulgaris, and how they should be combined as rational treatment. The indications for using oral antibiotics in acne will be highlighted. Strategies described in the literature to conserve the utility of oral antibiotics will be summarized. These include limiting the duration of antibiotic therapy, concomitant use of a topical non-antibiotic agent, use of subantimicrobial dose doxycycline, and the introduction of topical dapsone.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  acne; antibiotic resistance; benzoyl peroxide; oral antibiotics; subantimicrobial dose doxycycline; tetracycline; topical dapsone; topical retinoid

Mesh:

Substances:

Year:  2016        PMID: 27306750     DOI: 10.1111/dth.12370

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  15 in total

Review 1.  Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.

Authors:  Gabriela Schneider-Rauber; Debora Fretes Argenta; Thiago Caon
Journal:  Pharm Res       Date:  2020-11-09       Impact factor: 4.200

2.  Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacy.

Authors:  Ayman Grada; James Q Del Rosso; Emmy Graber; Christopher G Bunick; Linda Stein Gold; Angela Y Moore; Hilary Baldwin; Zaidal Obagi; Giovanni Damiani; Timothy Carrothers; Brian McNamee; Eva Hanze
Journal:  Dermatol Ther       Date:  2021-12-30       Impact factor: 3.858

3.  Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation.

Authors:  Xiaoyun Tang; Xianyan Wang; Yuan Y Zhao; Jonathan M Curtis; David N Brindley
Journal:  Mol Cancer       Date:  2017-02-08       Impact factor: 27.401

4.  Inhibitory effects of superoxide dismutase 3 on Propionibacterium acnes-induced skin inflammation.

Authors:  Cuong Thach Nguyen; Shyam Kishor Sah; Christos C Zouboulis; Tae-Yoon Kim
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

5.  FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.

Authors:  Alexandra Poinas; Marie Lemoigne; Sarah Le Naour; Jean-Michel Nguyen; Solène Schirr-Bonnans; Valery-Pierre Riche; Florence Vrignaud; Laurent Machet; Jean-Paul Claudel; Marie-Thérèse Leccia; Ewa Hainaut; Nathalie Beneton; Cécile Dert; Aurélie Boisrobert; Laurent Flet; Anne Chiffoleau; Stéphane Corvec; Amir Khammari; Brigitte Dréno
Journal:  Trials       Date:  2020-06-25       Impact factor: 2.279

6.  Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris.

Authors:  George Zhanel; Ian Critchley; Lynn-Yao Lin; Nancy Alvandi
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 7.  Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris.

Authors:  Angela Yen Moore; Jean Elizze M Charles; Stephen Moore
Journal:  Future Microbiol       Date:  2019-09-02       Impact factor: 3.165

Review 8.  Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation.

Authors:  Christopher G Bunick; Jonette Keri; S Ken Tanaka; Nika Furey; Giovanni Damiani; Jodi L Johnson; Ayman Grada
Journal:  Antibiotics (Basel)       Date:  2021-04-15

9.  Antimicrobial activity of certain natural-based plant oils against the antibiotic-resistant acne bacteria.

Authors:  Ahmed Esmael; Mervat G Hassan; Mahmoud M Amer; Soheir Abdelrahman; Ahmed M Hamed; Hagar A Abd-Raboh; Mohamed F Foda
Journal:  Saudi J Biol Sci       Date:  2019-11-20       Impact factor: 4.219

Review 10.  The Development of Third-Generation Tetracycline Antibiotics and New Perspectives.

Authors:  Aura Rusu; Emanuela Lorena Buta
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.